Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Kendall Company was a prominent American manufacturer of medical supplies and healthcare products, best known for its leadership in wound care and vascular therapy. Established in 1903, the company developed several iconic brands, including Curad bandages, Kerlix gauze, and T.E.D. anti-embolism stockings. Kendall was acquired by Tyco International in 1994 for approximately $1.4 billion, becoming a core component of Tyco Healthcare. Following the spin-off of Tyco Healthcare as Covidien and its subsequent acquisition by Medtronic in 2015, Kendall's legacy products remain integral to Medtronic's medical supplies portfolio. The company's historical focus spanned across surgical, vascular, and nursing care sectors, providing essential consumables to hospitals worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Kendall Company.